All posts by imreal

Numina Group joins forces with Waypoint Robotics to launch Innovative Autonomous Batch Cart Order Fulfillment Solution


RDS Batch-Bot

Numina Group’s RDS™ Warehouse Execution and Control Software Suite now includes a new Batch Bot Module to optimize, manage and track (AMR) activities, explains Numina Group CEO Dan Hanrahan.

Numina Group and Waypoint Robotics have teamed up to create a powerful autonomous batch order automated order picking solution. Numina Group’s Real-time Distribution Software, RDS™ Batch Bot Voice Picking Application integrates with Waypoint Robotics’ Vector Autonomous Mobile Robot, (AMR) to provide an innovative, highly efficient order picking solution. The RDS™ automation module uses pick by voice commands to direct operator zone movement and picking tasks while coordinating the Waypoint Vector AMR batch cart movement throughout the distribution center (DC). The AMRs, using the Kingpin technology, efficiently pick-up and move carts with heavy and/or large quantities of orders, allowing the operators to focus on the high value order picking duties. The Vector AMR Kingpin connects and drops carts quickly, resulting in higher hourly throughput per cart, and a more efficient pick, pack, and ship operation.

The solution simultaneously coordinates both the Waypoint AMR and order picking to eliminate wasted operator walk time and fatigue caused by manually pushing carts with up to 600 pounds of products throughout the DC. RDS™ directs the Vector AMR with Kingpin pick and drop technology, so the pick carts automatically move to each shelf or rack location. At pick completion RDS™ directs the AMR to transport the finished carts to packing workstations. Vector combined with the RDS™ Batch Bot solution provides higher order fulfillment efficiency, reducing labor costs by 40% or more compared to a manual cart picking process.

“Numina Group’s RDS™ Warehouse Execution and Control Software Suite now includes a new Batch Bot Module to optimize, manage and track (AMR) activities,” explains Numina Group CEO Dan Hanrahan. “The new software module extends the capabilities of our RDS™ Pick by Voice picking application so both the workers and the autonomous batch cart movements are coordinated throughout pick and pack. The Batch Bot module includes order release and prioritization, cartonization pick to carton, put to light order consolidation, and labor and order tracking performance metrics reporting.”

“Waypoint’s Kingpin is the first of its kind dual-use module that enables Vector and MAV3K AMRs to automatically load and unload payloads as well as hitch and transport carts of all sizes,” says Waypoint Robotics CEO, Jason Walker. “Now you don’t have to dedicate a robot for one task or another, with Kingpin you can do both. This combined with Numina Groups RDS order fulfillment automation suite creates a powerful but easy to use solution to improve worker productivity and safety by reducing the heavy lifting.”

About Numina Group:

Numina Group is a top tier integrator for improving and automating warehouse operations through a family of cutting-edge warehouse automation technologies managed and controlled by RDS™, our top tier WCS-WES Platform. The Numina Group partners with clients to define, design, and implement material handling and order fulfillment process improvements enhanced by automation technologies that optimize distribution practices to gain improved profitability.

Numina Group

10331 Werch Drive

Woodridge, IL 60517

630-343-2622

info@numinagroup.com

https://numinagroup.com/

@pickpackship

About Waypoint Robotics:

Waypoint Robotics, located in Nashua, NH, develops and manufactures fully autonomous mobile robots that are easy to use, industrial strength, and designed to be setup and used by the workforce that is on the job today. VectorTM, MAV3KTM, and supporting products can be put to work immediately, adding to workers’ capabilities, increasing their efficiency, and strengthening their companies.

Waypoint Robotics, Inc.

248 Main Dunstable Road

Nashua, NH 03062

603-288-1605

info@waypointrobotics.com

http://www.waypointrobotics.com

@waypointrobo

Share article on social media or email:

Breakthrough Dementia Homecare Solution Available Today at No Cost, Funded by National Institutes of Health


The solution comes with 1 Smart Home Center Gateway, 5 Motion Sensors, 3 Entry Sensors, 1 Amazon Echo Smart Speaker, 1 Wireless 1-Touch Button, 1 Water Leak Sensor, 2 CareActive Watches, 2 Nightlights, and Expert Installation Assistance.

Presence Family Care Pack, by People Power

“There’s a tremendous need to dramatically lower the cost of home care while helping seniors live in their homes longer. This project has already produced significant advancements in how senior and family care services can be delivered with today’s best technology and research”, said Gene Wang, CEO

People Power, a leading healthtech software company providing AI-powered services for senior care, announces today the availability of a caregiving system – Presence Caregiver – designed to address the everyday challenges of providing care for people with Alzheimer’s and other dementias. The free program is offered to caregivers living with a person who has received a diagnosis of dementia or mild cognitive impairment. Participating caregivers must be literate in English, have a smartphone and wireless internet connectivity in the home, and be willing to participate in intermittent study activities. Participants will receive the Presence Caregiver Research Pack and mobile app at no cost, a free Amazon Echo upon installation of the system, and each caregiver will earn at least $150 for completing quick-and-easy questionnaires.

Key findings from the collaborative study will reveal how an intelligent connected solution can be designed to assist in the effort of delivering better care for people with dementia while addressing all-too-common feelings of isolation, stress and loneliness of caregivers. The program is led by People Power and University California Berkeley’s Psychophysiology Laboratory, headed by Dr. Robert W. Levenson.

Visit https://research.presencefamily.com to answer 4 simple questions to see if you qualify to participate in this program.

“The next generation of truly intelligent home care systems must significantly improve the lives of caregivers and patients alike”, said Gene Wang, CEO and cofounder of People Power Co. “There’s a tremendous need to dramatically lower the cost of home care while helping seniors live in their homes longer. This project has already produced significant advancements in how senior and family care services can be delivered with today’s best technology and research.”

The Presence Caregiver Research Pack includes a variety of sensors that are installed in the home, similar to a security system, but without cameras. The sensors gather continuous pattern motion data and, using Artificial Intelligence (AI), create a safety net for the home that alerts caregivers to potential hazards. Data from sensors fuel a menu of helpful services that perform continuous monitoring of occupants. The easy-to-use mobile app connects to and integrates with the wirelessly connected sensors to help understand the real-time and historic activities in the home, distributes alerts, connects with a Trusted Circle of family and friends, and more.

The Presence Caregiver Research Pack provides a variety of helpful caregiving services:

Receive mobile alerts if something appears to be wrong

  • Know if someone wandered away from home
  • Know if they have likely experienced a fall


Track the current activities of occupants

  • Know if and when the front door opened
  • Know when medication was accessed


Better understand rest and sleep patterns

  • Know what time they went to bed and got up
  • Track sleep history and quality for improved health insights


Enable support from family and friends

  • Create and delegate helpful tasks to others
  • Coordinate family and friends to stay in contact


Improve safety at home

  • Call for help with the wirelessly connected button
  • Know immediately of a water leak or clogged toilet


Enjoy voice control services with Amazon Echo

  • Easily request helpful reminders to take medications
  • Make phone calls, check weather, and play music


Join and participate in a caregiving community

  • Connect with and receive online advice from caregivers
  • Get invited to in-person meetings with fellow caregivers


The program is supported by the National Institutes of Health’s National Institute on Aging through a Small Business Innovation Research grant, #R44 AG059458-01

About People Power

An IoT software company specializing in the development of consumer services for senior care, energy management and home security, People Power leads the industry with advanced AI-powered connected home solutions delivered through brands seeking recurring revenue business growth. For more information visit peoplepowerco.com

Share article on social media or email:

Endovascular Consultants of Colorado (ECCO), The Best Endovascular Specialists in Colorado, Launches New Patient-Centric Website


Best Endovascular Group

Worldclass Endovascular Care

ECCO provides advanced vascular and interventional radiology services on an outpatient basis, serving patients while working collaboratively with referring physician colleagues.

ECCO, a top endovascular center in Colorado, has launched a new patient-centric website. The new site, online at http://www.endovascularexperts.com, is designed to provide Denver area patients with high-quality information about today’s advanced, minimally-invasive arterial, venous, cancer, men and women’s treatments, and other leading-edge radiology therapies.

ECCO, which stands for Endovascular Consultants of Colorado, is a newly formed practice in Lone Tree, Colorado that focuses on interventional radiology, specifically for patients with the following disease states: metastatic cancer to the liver, peripheral arterial disease, benign prostatic hypertrophy, uterine fibroids, pelvic congestion syndrome, venous insufficiency, venous obstruction, non healing wounds and leg swelling. ECCO’s main priority for their new website was therefore to provide patients with accurate, helpful information about treatments and how their practice helps patients to achieve their best outcomes. “Our entire team is extremely pleased with how the site has turned out,” said Dr. Aaron Kovaleski, ECCO’s Founder and one of its physicians.

ECCO physician, Dr. Charles Nutting added, “Our goal is to provide patients with useful information about the treatments we offer in a patient-friendly, easy-to-understand format. It was important for us to align our message and services with our patient’s online search habits as most patients now research their doctors and procedures online.”

The ECCO website features educational articles, videos and descriptions of the center’s leading, minimally-invasive treatments for different types of men and women’s diseases with a focus on peripheral artery disease and liver cancer treatments. The site is easy to navigate and features an original, visually-appealing design created by innovative healthcare growth strategy and design firm, Paramount/MD. Patients can visit the site to learn more about interventional radiology and cancer treatment by going to: http://www.endovascularexperts.com.

Treatment Options

Similar to radiologists, ECCO helps to diagnose cancers and other disorders. As Denver’s interventional oncology specialists, the practice focuses on high-end, minimally-invasive procedures used to treat different types of cancer. These procedures include microwave and cryoablation, chemoembolization or radioembolization of tumors, portal vein embolization, and treatment of bony metastases. Many of these tumors occur in the liver, and these procedures allow ECCO to provide the most advanced liver cancer treatment in Colorado as well as nationally.

In addition, ECCO serves as a top peripheral vascular disease center in Colorado, specializing in lower extremity arterial revascularization, endovenous laser therapy and venous stent placement.

The center also devotes a part of its practice to the treatment of problematic women’s health issues, such as female pelvic pain due to uterine fibroids, pelvic congestion syndrome, or May-Thurner Syndrome; and men’s health issues such as benign prostate hyperplasia (BPH) with prostate artery embolization (PAE), or varicocele (one of the many causes of infertility) with gonadal vein embolization.

About ECCO

ECCO is a medical practice based in Lone Tree, CO that focuses on interventional radiology and minimally invasive options for a variety of patient conditions – including oncology, wounds, leg pain, and men’s/women’s health issues. The practice is located at 8080 Park Meadows Drive, Suite 130 Lone Tree, CO 80124 in the new, state-of-the-art outpatient center, with its top-line facilities and technology and “patient-centric” approach.

Aaron Kovaleski, MD and Charles Nutting, DO are board certified in both Diagnostic Radiology and Vascular and Interventional Radiology. They have both practiced for a collective 33 years, receiving excellent feedback from the doctors and patients they have worked with. ECCO specialists consult with patients and their primary doctors, perform the appropriate procedure, and follow up with them just as any surgeon would—though not within the boundaries of a large diagnostic radiology group. Instead, ECCO is a free-standing interventional radiology practice, dedicated to patient-centric care and staying on top of and in front of the most exciting advances in the treatment of a variety of women’s and men’s health issues, with a strong focus on lower extremity arterial disease and liver cancer.

ECCO is the only Office Based Laboratory (OBL) in the Denver metro area doing arterial interventions of any kind, including leg revascularization. It is also the only full time, fully operational OBL in Colorado and the only practice in Colorado performing liver cancer treatments in an outpatient center. Dr. Charles Nutting leads this initiative and is nationally recognized as a leader in this field. He has been on the forefront of IR advancement in this area and he and Dr. Aaron Kovaleski are two of 40 proctors in the US for Y90 radioembolizaiton – an endovascular cancer therapy in which radioactive beads are injected through the arteries into tumors that have spread to the liver. Dr. Nutting did the first one in the US nearly 20 years ago and the 100,000 in 2019.

Dr. Nutting is one of a handful of people in the country that also performs prostate artery embolization (PAE). It treats a benign syndrome in males called benign prostatic hypertrophy (BPH), and is considered one of the most technically challenging procedures in IR. He does the most of anyone in the country and travels the US training people in his techniques. To date, he has performed over 350 prostate embolizations and was recently honored to coauthor a chapter, From Patient Selection To Advanced Embolization Techniques, in his industry’s only book dedicated to PAE called, “Prostatic Artery Embolization.”

Dr. Kovaleski is a specialist, trainer, and speaker for Peripheral Arterial Disease (PAD) intervention. He is currently the only physician in the state of Colorado doing limb salvage in an OBL, and one of a “very small number” of physicians doing specialized below knee treatments for limb salvage. Additionally both he and Dr. Nutting are certified in wound care and skilled to treat the entire spectrum of vascular causes of wounds.

The practice works with the best oncologists, radiation oncologists, surgical oncologists, podiatrists, primary care physicians, nephrologists, endocrinologists, urologists, and ob/gyn’s in the area to provide the most advanced minimally-invasive outpatient treatment options in Colorado. The treatment center’s use of minimally-invasive procedures helps lower the cost of treatment while reducing the patient’s risks associated with more invasive treatments. ECCO is Medicare certified and they accept most types of insurance.

ECCO

Contact: info@endovascularexperts.com

http://www.endovascularexperts.com Tel. 720-250-9799

ServiceMaster DSI Helps with the Coronavirus Outbreak


ServiceMaster DSI, the nation’s largest owner and operator of ServiceMaster Franchises has increased efforts to assist with the COVID-19 (Coronavirus) outbreak. With new cases of coronavirus infection being reported daily and the impact being felt across the globe, ServiceMaster DSI has committed their own resources to further the education, communication and treatment of facilities possibly impacted by or preparing for COVID-19.

Concentrating on the treatment and decontamination of facilities and buildings, the experts at ServiceMaster DSI have identified several disinfection procedures and systems to help provide the most effective results available. Researching and testing various decontamination methods is something ServiceMaster DSI does continuously, however special precautions need to be taken in extreme situations such as the COVID-19 outbreak.

Complicating the task of proper decontamination and disinfection is the fact that information about COVID-19 is scarce and changes regularly. ServiceMaster DSI has committed resources to monitor changes and developments from respected sources such as the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) as well as communicate regularly with clients, field personnel and other ServiceMaster network partners. This constant research, education and communication provide ServiceMaster DSI with valuable information not only about the virus itself, but the reaction of people and businesses related to news reports and potential challenges with decontamination.

“Through our ServiceMaster DSI and SRM brands, we have clients and relationships across the country as well as internationally. It is our duty to stay ahead of any aspect that may negatively impact our clients’ businesses including the Coronavirus outbreak. We have committed our own resources including personnel, equipment and funds for aspects such as educational opportunities and client coordination to make sure we are best prepared to help any way we can.” Jim Boccher – President and CEO ServiceMaster DSI / SRM

In addition, ServiceMaster DSI has brought industry experts such as industrial hygienists and disease control professionals into their offices to collaborate on various topics surrounding the COVID-19 outbreak and possible decontamination methods. With so many businesses and facilities under the threat of being impacted by the Coronavirus these developments and proactive measures may prove critical in the coming days and weeks.

DSI Holdings is an ownership/management group headquartered in Downers Grove, IL specializing in providing residential and commercial disaster restoration services through the ServiceMaster DSI and ServiceMaster Recovery Management (SRM) brands. Starting with its first ServiceMaster license in 1981, DSI Holdings has grown to be the premier ownership group within the ServiceMaster network, amassing 87 licenses within the United States and serving as the flagship SRM operator. Through these brands, DSI services clients in all 50 states and its large loss team has provided commercial disaster restoration services in more than 20 countries around the world.

Share article on social media or email:

Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil


Hospital PUC-Campinas Celso Pierro is a reference hospital in high-complexity care in Campinas, São Paulo, and surrounding regions, with 339 beds. The hospital runs clinical trials in cardiology, dermatology, endocrinology and haematology, among others.

By joining the Patient Network Explorer platform, patients at Hospital PUC-Campinas Celso Pierro will gain visibility when sponsors are seeking patient cohorts and selecting sites for clinical trials. Patient Network Explorer matches sponsors’ trial protocols to the anonymized EHR data of patients in Clinerion’s hospital network.

“The partnership with Clinerion and the implementation of the Patient Network Explorer system is very important for the Clinical Research Center of the Hospital PUC-Campinas because we believe that the system will increase the number of randomized patients in our clinical research studies in a short time,” says Dr. Danilo Villagelin, Director of the Clinical Research Center. “The field of clinical research studies is very competitive and we expect partnership with Clinerion to bring us great benefits in efficiency and efficacy of running trials.”

“iHealth, as a partner of Clinerion in Brazil, is determined to connect more and more reference research centers in Brazil, like the Hospital PUC-Campinas, attracting more clinical studies and financial resources to Brazilian institutions,” says Leonardo Nunes Alegre, COO of iHealth.

“Clinerion is determined to provide more treatment options to patients and their physicians in Brazil by bringing more international clinical trials to the country,” says Ian Rentsch, CEO of Clinerion. “Brazil is a vast country with vast possibilities for clinical research. Our expansion throughout the major metropolitan areas of the country demonstrates our commitment to both patients and the development of innovative medical interventions. We are proud to count Hospital PUC-Campinas Celso Pierro as a partner.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

About iHealth Group

The iHealth Group has a multidisciplinary team focused on serving the health informatics industry. Our team has extensive experience in this topic, leading the process of computerization of more than 30 Brazilian hospitals. Digital health transformation will enable us to improve communication with our patients, optimize our queues, improve the safety of our processes, expand our planning capacity, reduce costs, eliminate waste and, especially, do evidence-based management. However, we must understand that it is not the technology, but strategic management that will guide us correctly to the computerization of our health processes. IT cannot be a strategic goal, but an instrument to achieve a goal.

iHealth Group website: http://www.ihealthgroup.com.br

For more information, please contact:

Leonardo Nunes Alegre

iHealth Group

Tel.: 55 51 9 9192-9222

leonardo.alegre@ihealthgroup.com.br

About Hospital PUC-Campinas Celso Pierro

Hospital PUC-Campinas Celso Pierro website: http://www.hospitaldapuc-campinas.com.br.

For more information, please contact:

Crislaine Gava

Hospital PUC-Campinas Celso Pierro

Av. John Boyd Dunlop, s/n° Jardim Ipaussurama, Campinas – SP – CEP: 13060-904, Brasil

Tel.: +55 (19) 3343-8332

crislaine-gava@hospitaldapuc-campinas.com.br

Share article on social media or email:

ACDi’s North Carolina Manufacturing Plant Installs New Koh Young 3D SPI and AOI Equipment


ACDi

ACDi, a leading electronics manufacturing services provider, announces the most recent capital investment in printed circuit board inspection technology and equipment at their Nashville, North Carolina factory. Final equipment installation and training was recently completed incorporating 3D imaging technology at its Nashville facility with the addition of Koh Young KY8030-3 3D Solder Paste Inspection and Koh Young Zenith Alpha HS 3D Automated Optical Inspection Systems.

Electronics manufacturing industry standards estimate approximately 70% of surface mount technology (SMT) process-related defects originate from the solder paste printing process. Though most all SMT screen printing systems at a minimum incorporate 2D AQL selective inspection capability, having newly installed 3D solder paste inspection (SPI) verifies not only area (L/W) coverage of paste, but also analyzes third dimension volumetric deposition of solder paste. Adding this capability as an inline standalone machine directly behind the printer reduces the screen printer cycle time while also enabling 100% 3D real time total board paste inspection, stopping the process and prompting immediate operator process engagement and equipment adjustment as necessary. Additionally, the KY 8030 SPI system is Industry 4.0 capable for direct machine-to-machine interface with the factory’s Juki G-Titan automated printing system.

Additionally, once 3D SPI process verification has been assured, populated circuit board post reflow 3D Automated Optical Inspection (AOI) capability now validates not only 2D component placement accuracy related to presence, X/Y alignment, orientation and character recognition, but also enables third dimension imaging to verify Z-height factors including coplanarity, lifted leads, discrete SMD head-in-pillow (HiP), bridging, and overall solder joint integrity (insufficient or excess).

ACDi selected Koh Young, not just because they are the leader in number of 3D SPI and AOI systems installed, but to also offer commonality of equipment manufacturers at both our Frederick MD Corporate and Nashville NC production facilities. Standardizing on equipment supports business continuity factors where transition between locations adds value, and also facilitates collaboration among production and engineering staff at both sites further encouraging achievement of one of ACDi’s Fundamental Pillars of Success, a Team Oriented Workforce!

About ACDi

Based in Frederick, MD and Nashville, NC, American Computer Development Inc. (ACDi) is an integral resource to companies who need a trusted partner for dynamic electronics manufacturing, engineering and design expertise to successfully bring their electronic products to market. Our product engineering support services, PCB layout, NPI, electronics manufacturing services, testing, systems integration and product lifecycle management solutions enable OEMs to focus on their business while we focus on product realization and optimization. ACDi clients gain a hands-on extension to their business as we turn their concepts into functional product. Learn more about ACDi on their website http://www.acdi.com/.

Share article on social media or email:

The Quinism Foundation and Veterans for Common Sense Call on Congress to Fund Research into Chronic Quinoline Encephalopathy


The Quinism Foundation and Veterans for Common Sense are calling on Congress to fund critical research into the chronic adverse neurological and psychiatric effects of mefloquine and related quinoline antimalarial drugs, following release of a report by an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM). The NASEM committee was charged by the U.S. Department of Veterans Affairs with looking at “long-term health effects” of antimalarial medication, with “special attention” “to possible long-term neurologic effects,” and “long-term psychiatric effects.” [1]

On February 25, 2020, the NASEM committee publicly released its final report. It observed a “disconnect between the level of concern raised–millions of people have used the drugs, and there are many known concurrent events and case reports of adverse events–and the systematic research that has been conducted, particularly in areas such as the use of mefloquine and persistent neurological or psychiatric outcomes.” The committee found “there is a sharp contrast between the abundant amount of literature pertaining to concurrent adverse events that are experienced while a drug is being used or shortly following its cessation and the dearth of information, especially high-quality information, pertaining to adverse experiences after the use of that drug has ended.” [1]

“To address the critical research needs identified by NASEM, Congress should establish chronic quinoline encephalopathy (neuropsychiatric quinism) as a perennial research topic under the Peer-Reviewed Medical Research Program (PRMRP) within the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP),” said Remington Nevin, MD, MPH, DrPH, executive director of The Quinism Foundation.

The Quinism Foundation and Veterans for Common Sense identified five focus areas for future research, including conducting high-quality epidemiological studies related to persistent health effects of antimalarial quinolines, particularly mefloquine.

“In a chapter titled ‘Improving the Quality of Research on the Long-Term Health Effects of Antimalarial Drugs,'” Dr. Nevin said, “the committee noted the importance of epidemiological study designs that ‘allow for the discovery of symptoms or diagnoses that covary. For example, if certain symptoms or diagnoses occur together in the same patients, there may be reason to consider a syndrome of “neuropsychiatric” symptoms that co-occur, rather than looking individually at separate neurologic or psychiatric experiences.’ The committee also noted that a ‘challenge when studying adverse events of drugs is that the occurrence of adverse events [e.g. prodromal psychiatric symptoms such as nightmares, insomnia, anxiety, depression, restlessness, and confusion during use of mefloquine (i.e., symptomatic exposure)] may cause an individual to decide to modify the dose, or even stop the drug completely, without consulting a health professional.'”

“This focus area should aim to fund epidemiological studies meeting the NASEM Committee’s criteria relative to persistent health effects of antimalarial quinolines, particularly mefloquine – to include valid assessment of symptomatic quinoline exposure and particularly symptomatic mefloquine exposure, and subsequent covarying symptoms or diagnoses consistent with the described presentation of chronic quinoline encephalopathy,” Dr. Nevin said.

Other focus areas identified include defining persistent central nervous system effects of antimalarial quinoline neurotoxicity, defining adverse neurophysiological effects of antimalarial quinolines, disentangling comorbid neuropsychiatric diagnoses confounded by antimalarial quinoline toxicity, and developing effective treatments.

Dr. Nevin said that, “this latter focus area should aim to develop treatable targets and treatments for patients with putative chronic quinoline encephalopathy – including those diagnosed with PTSD or TBI – to improve their health and lives.” Dr. Nevin said in this respect that, “although the committee wrote in its report that it held open sessions during their study to ‘listen to individual veterans and others, such as spouses and advocates, who are concerned about aspects of health that may be related to use of these antimalarial drugs’, the committee was prohibited from reviewing patient reports.”

“Had the committee been directed or allowed to review the medical records of affected patients, the unmet clinical needs of these individuals would have likely been readily apparent,” said Anthony Hardie, National Chair and Director of Veterans for Common Sense, a national veterans organization.

About The Quinism Foundation

The Quinism Foundation, founded in January 2018, in White River Junction, Vermont, promotes and supports education and research on quinism, the family of medical disorders caused by exposure to quinoline drugs, including mefloquine and tafenoquine. Dr. Remington Nevin, Executive Director of The Quinism Foundation, is a board-certified occupational medicine and preventive medicine physician and former U.S. Army medical officer and epidemiologist. He is author of more than 30 scientific publications on malaria and the quinoline antimalarials.

1. National Academies of Sciences, Engineering, and Medicine 2020. Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis. Washington, DC: The National Academies Press. Available at: https://doi.org/10.17226/25688.

Share article on social media or email:

Judy Lohr’s newly released “Relapse Prevention Workbook” is a fundamental guide that will help the readers stay sober and drug free


News Image

“Relapse Prevention Workbook”: a masterful guide that encourages and leads the recovering alcoholic/addict through the mine fields and temptations that could lead them back to their addictive behaviors. “Relapse Prevention Workbook” is the creation of published author Judy Lohr, a licensed clinical social worker with many years of experience in addiction treatment, marriage and family therapy, adolescent counseling, and individual and group therapy. She has a private practice where she still counsels addicts and alcoholics.

Lohr writes, “This guide is for anyone who has stopped using alcohol or other drugs and wants to stay sober and drug-free. Successful sobriety involves more than just the desire not to drink or use–it also involves hard work. Here you’ll find the tools you need to begin.

“This workbook is designed to help you stay sober. It is not meant to take the place of a Twelve Step group, counseling, or an aftercare program. It is to be used in conjunction with them.

“Whether you were addicted to cocaine, heroin, marijuana, alcohol, prescription drugs, or any other mind-altering chemical, the tools offered in this guide are meant to help you avoid relapse.”

Published by Christian Faith Publishing, Judy Lohr’s new book is a brimful workbook that allows the readers to understand what relapse is and its other negative effects in life.

With this purpose, Lohr aims to help the readers find a helpful tool that allows them to ask questions, clarify what they have learned, and gain support for those difficulties that might surface through their work in this guide.

View a synopsis of “Relapse Prevention Workbook” on YouTube.

Consumers can purchase “Relapse Prevention Workbook” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Relapse Prevention Workbook,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

CMR Announces FDA Clearance of MRH Series of Radiological Systems


CMR, a developer and manufacturer of technological solutions for medical diagnostic imaging and information technology, has received FDA clearance for its MRH Radiological Series which include the MRH Alfa, MRH II and MRH IIE Radiographic Systems.

The MRH Radiographic Systems are designed for general radiographic applications such as extremity, head, abdominal and thoracic imaging. Equipped with state-of-the-art control technology that permits to perform studies quickly and efficiently which leads to increased productivity. The control console features an anatomical programmer for fast and accurate radiographic technic selection. The system can be configured with one or more digital detector. Compact design and minimal pre-installation requirements facilitate installation in areas of limited space.

The MRH Series, the previously FDA cleared ARiX RAD System, Information Technology Systems and Molecular Breast Imaging Systems are available globally through direct and indirect distribution channels.

About CMR: CMR, Compañia Mexicana de Radiologia CGR, S.A. de C.V., is a global developer and manufacturer of high-quality diagnostic imaging equipment and healthcare information systems, including DICOM-compliant software. Established in 1973, CMR is headquartered in Queretaro, Mexico, location of its x-ray and information technology development and manufacturing facilities. CMR X-Ray, LLC based in Waukesha, Wisconsin designs and manufactures medical x-ray generators that are suitable for OEM and x-ray dealer applications. CMR Molecular Imaging, a unit of CMR Naviscan Corporation which is based in Carlsbad, California develops and manufactures high resolution Molecular Breast Imaging systems. For more information visit:

http://www.cmr-rx.com

http://www.cmr-naviscan.com

Share article on social media or email:

Lacrosse Unlimited scores three all stars in continued Team expansion


Lacrosse Unlimited is proud to announce the continued expansion of the Institutional Sales and Production Team with the addition of Kevin Simmons and Rob Rochford in Sales and Mitch Mendel in Production.

Kevin comes to Lacrosse Unlimited after 6 years with Maverik Lacrosse where he served as Sports Marketing Manager. Kevin earned a BS in Business Administration from Saint Michael’s College where he served as team captain his Senior year. Kevin is a resident of Ridgefield, NJ and attended Don Bosco Prep where he was a three-sport athlete. Kevin joins the team as Director of Institutional Sales, will be based in New Jersey, and will play a key role in expansion our of Institutional footprint in a region we currently enjoy a strong retail presence.

Rob brings with him nine years of experience in Institutional Sales, E-Commerce, and Webstore design, having previously worked at several smaller companies in the industry prior to joining our team. Rob is a graduate of Manhattanville

College and received a MA in Education from Adelphi University. Rob joins LU as Team Store Director of Institution Sales and will be tasked with drawing from his experience to continue to grow our customer base, create strategic solutions to our current team webstore offerings, and support strategic initiatives as we expand the offerings from UNLTD TEAM.

Simmons and Rochford will report to Sean Haggerty, EVP of Institutional Sales and will play a key role in the ongoing expansion of Lacrosse Unlimited institutional and team sales efforts.

“We are excited to have Kevin and Rob join our team and leverage their deep industry knowledge, relationships, and skillset to continue our expansion into the marketplace” says Haggerty. “In addition, being former collegiate athletes and current coaches, Rochford and Simmons bring a unique understanding of customer expectations, which combined with their capabilities, will serve our expansive and growing customer base well.”

Mitch joins Lacrosse Unlimited after growing his own Print and Embellishment company for the past 10 years. Mitch’s brings a deep technical industry knowledge, combined with a unique understanding of customer expectations and sense of urgency that will benefit our production team greatly. As the Head of Production, Mitch will be immediately tasked with improving quality while decreasing turnaround times. Mitch will report to Sean Haggerty and work closely with his team to streamline and improve all aspects of the order management and production process.

“We couldn’t be happier how we’ve been able to add three consummate professionals to our Intuitional effort. Kevin, Rob, and Mitch each personify the values that have come to define Lacrosse Unlimited and I am looking forward to having them part of our family”, said Joe DeSimone, CEO and Founder of Lacrosse Unlimited.

About Lacrosse Unlimited:

Founded in Long Island, New York, Lacrosse Unlimited has been a go-to resource for all things in the popular sport. Launched in 1990 by Joe DeSimone and his family, the company has become the most innovative tastemaker in lacrosse, now with 43 stores across twelve states. Lacrosse Unlimited is renowned for its genuine passion for the sport, and for its relentless focus on providing an “always-custom” experience to its clients.

Share article on social media or email: